Middlefield Income Plus II Corp T.MIP

An email about the sales from Bolduc

[Cloud_Strife]

Hi Mr. xxxx, In fact, there will be some marketing costs incurred in Fiscal Q3 and following (to be reported in Feb 08), very low production costs only (margin is interesting). First sales (fiscal Q3) will be reported in Feb 08 with the main sales to be reported in Fiscal Q4 (results to be issued in June 08) Until that time, speculation on Instillagel’s sales will be just that, speculation. Thanks BB Bertrand F. Bolduc, B.Pharm., MBA President & CEO Mistral Pharma Inc. TSX Venture: MIP 1717, Trans-Canada Dorval , Québec , Canada , H9P 1J1 Tel: [phone] # 2224 Mobile: [phone] Fax: [phone] [e-mail] www.mistralpharma.com